Your browser doesn't support javascript.
loading
Chemoprophylaxis vaccination with a Plasmodium liver stage autophagy mutant affords enhanced and long-lasting protection.
Sahu, Tejram; Gehrke, Ella J; Flores-Garcia, Yevel; Mlambo, Godfree; Romano, Julia D; Coppens, Isabelle.
Affiliation
  • Sahu T; Department of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. tsahu1@jhu.edu.
  • Gehrke EJ; Department of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Flores-Garcia Y; Department of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Mlambo G; Department of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Romano JD; Department of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Coppens I; Department of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. icoppen1@jhu.edu.
NPJ Vaccines ; 6(1): 98, 2021 Aug 10.
Article in En | MEDLINE | ID: mdl-34376691

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Vaccines Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: NPJ Vaccines Year: 2021 Document type: Article Affiliation country: United States Country of publication: United kingdom